Lineage Cell Therapeutics, Inc. (LCTX)
1.765
+0.06
(+3.22%)
USD |
NYAM |
Jan 12, 16:00
1.75
-0.02
(-0.85%)
After-Hours: 18:37
Lineage Cell Therapeutics Shareholders Equity (Quarterly): 22.04M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ocugen, Inc. | 3.533M |
| Belite Bio, Inc. | 274.08M |
| ProKidney Corp. | -1.008B |
| CEL-SCI Corp. | 15.96M |
| AIM ImmunoTech, Inc. | -6.077M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 89.64M |
| Total Liabilities (Quarterly) | 68.84M |
| Debt to Equity Ratio | 0.1189 |
| Current Ratio | 4.504 |
| Net Debt Paydown Yield | 0.02% |